Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has informed BSE that its trading window for insiders will be closed from 1st October 2025 onwards. The window will reopen only 48 hours after the company declares its unaudited financial results for the quarter ended 30th September 2025 (Q2 FY26). During this period, designated persons and their immediate relatives are prohibited from trading in the company's shares. The Board meeting date for approving the Q2 results will be announced separately.
This is a routine compliance requirement under SEBI insider trading rules and signals that Q2 FY26 results are approaching. No direct impact on retail shareholders or stock price is expected from this intimation itself.